Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

February 4, 2025

The Advocate: "2024 Game Changers: How Specialty Pharmacies Can Thrive Amid Shifts in Cybersecurity, PBM Reforms, and Regulations"

Brad Gallagher and Linda Clark, Health Care Controversies Team co-leaders, had their “2024 Game Changers: How Specialty Pharmacies Can Thrive Amid Shifts in Cybersecurity, PBM Reforms, and Regulations” article published in The Advocate, the National Association of Specialty Pharmacy’s member newsletter. The article highlights key events in 2024 that affected specialty pharmacies, including legislation to increase oversight and regulation of pharmacy benefit managers (PBMs) and fallout from the Change Healthcare cyberattack. 

The article also provided an outlook for 2025 regarding anticipated changes at the Federal Trade Commission and Medicare Part D–related issues. Brad and Linda wrote, “With continued scrutiny on PBMs, the growing risk of cybersecurity threats, and ongoing changes in federal and state regulations, it is essential that pharmacies take action to safeguard their operations and ensure compliance with new laws and contractual requirements.” 

Click here to read the full article.

Featured Media

Alerts

Changes to Delaware Corporate Law Aim to Preserve Its Leadership Position

Alerts

Non-Judicial Collateral Remedies, Part 1 – Collection and Enforcement Rights

Alerts

Recent US Supreme Court Decision Will Spur ERISA Litigation

Alerts

Proposed Endangered Species Act Change Seeks to Redefine "Harm"

Alerts

Natural Gas Bans in New York State Take Shape: Exemptions and Lawsuits Under Scrutiny

Alerts

Here We Go Again: Second Circuit Makes Additional Certification Attempt Regarding the New York Foreclosure Abuse Prevention Act

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out